Clinical Characteristics and Outcomes of Acute Ischemic Stroke in Patients with Type 2 Diabetes: A Single-Center, Retrospective Study in Southern China

Table 5

Comparison of mRS scores at discharge after rtPA thrombolytic therapy of both groups.

Group	n	mRS score: 0–2 (favorable prognosis)	mRS score: 3–6	Proportion (mRS score: 0–2)
NDM	61	40	21	0.656
DM	24	13	8	0.542
Χ^2	—	—	—	0.092
value	—	—	—	0.762

. mRS: modified Rankin Scale; rtPA: recombinant tissue plasminogen activator; NDM: no diabetes mellitus.